Alberto
Esteban Fernández
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (11)
2023
-
Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?
Cardiology, Vol. 148, Núm. 3, pp. 195-206
-
Gut Microbiota and Derived Short-Chain Fatty Acids Are Linked to Evolution of Heart Failure Patients
International journal of molecular sciences, Vol. 24, Núm. 18
2022
-
Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan
REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122
2021
-
Initiation and titration of sacubitril/valsartan in different types of centers
REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97
-
Predictors of clinical improvement in heart failure patients with iron deficiency treated with ferric carboxymaltose
REC: CardioClinics, Vol. 56, Núm. 4, pp. 250-257
2020
-
Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282
-
Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort
Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 65-69
-
Selection of the best of 2019 in geriatric cardiology
REC: CardioClinics, Vol. 55, pp. 3-9
2019
-
Sacubitril/Valsartan in Daily Clinical Practice: Data from a Prospective Registry
Journal of Cardiovascular Pharmacology, Vol. 73, Núm. 2, pp. 118-124
-
Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort
ESC Heart Failure, Vol. 6, Núm. 6, pp. 1161-1166
-
Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan
Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 73-78